NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘seed stage’

8 July 2014

Former GlobeSpan Capital exec bags $32m for debut seed-stage fundp

Ullas Naik Streamlined Ventures Seed-stage investment firm Streamlined Ventures has trounced its $25m target for its debt fund by pulling in more than $32m, AltAssets can reveal.

30 June 2014

Seed-stage investor SoftTech closes fourth fund on $85m

Money Seed-stage investor SoftTech VC has closed its fourth fund on $85m, bringing its capital under management to $155m.

6 June 2014

Kickstart passed halfway mark for $40m fundp

salt lake Salt Lake City-based firm Kickstart is more than halfway to the $40m target for its third fund, AltAssets has learned.

30 April 2014

Lerer Ventures seeks $50m for fourth fundp

Ken Lerer - Lerer Ventures - AltAssets Private Equity News Venture capital firm Lerer Ventures has launched its fourth fund, AltAssets has learned.

26 March 2014

Seed-stage deal making hits ten year lowsp

While last year saw the lowest number of seed deals in ten years, investments into seed stage businesses surged 14 per cent in terms of dollars.

20 March 2014

Boston Seed Capital launches $20m fundp

Westview Boston Seed-stage venture investor Boston Seed Capital is seeking $20m for its second fund, AltAssets has learned.

11 March 2014

Metamorphic Ventures closes second fund on nearly $70m

new york 5_sq Metamorphic Ventures has raised almost $70m for its second fund, making it much larger than the New York-based seed-stage investor’s $20m debut vehicle.

11 March 2014

SoCal’s TYLT Lab launches early stage investment fund

California-based advisory group TYLT Lab has launched an early stage fund focused on seed-to-A round investments.

14 February 2014

Disney teams with Techstarts for seed-stage accelerator programme

Media and entertainment group the Walt Disney Company has launched a new seed-stage investment programme, the Los Angeles-based Disney Accelerator.

21 January 2014

French biopharma developer Synthelis secures seed investment

French biopharmaceutical developer Synthelis has secured initial backing of €610,000 from investors comprising Rhone-Alpes Creation, Alpes Developpement Durable Investissement (A2D-Invest), Sud Rhone-Alpes Capital, Viaduc and the Savoy and Grenoble Business Angels networks.

Page 1 of 712345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014